Suxamethonium

Role

Indications

Reactions

Secondary

Drug Use For Unknown Indication	25.9%
Anaesthesia	11.6%
Product Used For Unknown Indication	10.2%
Drug Exposure During Pregnancy	9.8%
General Anaesthesia	9.2%
Prophylaxis	5.3%
Epidural Anaesthesia	3.9%
Induction Of Anaesthesia	3.9%
Epilepsy	2.7%
Hypertension	2.5%
Anaesthesia Procedure	1.8%
Analgesic Therapy	1.8%
Paralysis	1.8%
Maintenance Of Anaesthesia	1.6%
Neuromuscular Blocking Therapy	1.6%
Pulmonary Hypertension	1.6%
Poor Quality Sleep	1.4%
Antibiotic Therapy	1.2%
Bipolar I Disorder	1.2%
Hypopituitarism	1.2%

Therapeutic Agent Toxicity	16.4%
Rash Macular	8.2%
Thrombocytopenia	8.2%
Cardiac Arrest	6.8%
Circulatory Collapse	5.5%
Incorrect Route Of Drug Administration	5.5%
Live Birth	5.5%
Ventricular Fibrillation	5.5%
Anaphylactic Shock	4.1%
Hypotension	4.1%
Pulse Absent	4.1%
Respiratory Arrest	4.1%
Anaphylactic Reaction	2.7%
Cardiovascular Disorder	2.7%
Drug Exposure During Pregnancy	2.7%
Exposure During Pregnancy	2.7%
Oxygen Saturation Decreased	2.7%
Sinus Bradycardia	2.7%
Skin Reaction	2.7%
Transverse Presentation	2.7%

Concomitant

Product Used For Unknown Indication	23.8%
Anaesthesia	11.3%
Drug Use For Unknown Indication	9.4%
Sedation	7.8%
Induction Of Anaesthesia	6.6%
Maintenance Of Anaesthesia	5.9%
Premedication	3.8%
Epilepsy	3.1%
Perioperative Analgesia	3.1%
Procedural Nausea	3.1%
Pain	2.8%
Anxiety	2.5%
Endotracheal Intubation	2.5%
Pulmonary Embolism	2.5%
Anesthesia	2.2%
Hypotension	2.2%
Status Epilepticus	2.2%
Analgesic Therapy	1.9%
Prophylaxis	1.9%
Blood Pressure Management	1.6%

Therapeutic Agent Toxicity	10.4%
Hypotension	6.3%
Loss Of Consciousness	6.3%
Rhabdomyolysis	6.3%
Sinus Tachycardia	6.3%
Ventricular Tachycardia	6.3%
Anaphylactic Shock	4.2%
Chest Discomfort	4.2%
Malaise	4.2%
Overdose	4.2%
Persistent Foetal Circulation	4.2%
Phaeochromocytoma	4.2%
Premature Baby	4.2%
Somnolence	4.2%
Status Epilepticus	4.2%
Swollen Tongue	4.2%
Tryptase Increased	4.2%
Urinoma	4.2%
Ventricular Dysfunction	4.2%
Ventricular Fibrillation	4.2%